Cargando…
The Treatment for a Patient with Cancer of Unknown Primary: A Case Report
BACKGROUND: Cancer of unknown primary (CUP) is metastatic at diagnosis with an unknown primary site, indicating a high degree of malignancy with a poor prognosis. The development and application of targeted therapy and immunotherapy are current research hotspots, which provide additional treatment o...
Autores principales: | Ni, QingTao, Lu, KaiJin, Pan, Chi, Dai, ShengBin, Wang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649461/ https://www.ncbi.nlm.nih.gov/pubmed/34887715 http://dx.doi.org/10.1177/15593258211056185 |
Ejemplares similares
-
Immunotherapy Combined with Chemotherapy as a Promising Therapy for a EGFR Exon 19 Deletion with MET Amplification Patient with Non-Small-Cell Lung Cancer: A Case Report
por: Ni, QingTao, et al.
Publicado: (2020) -
A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma
por: Ni, Qingtao, et al.
Publicado: (2022) -
Success of (125)I-Seed Treatment in Vulvar Squamous-Cell Carcinoma with Aplastic Anemia: A Case Report
por: Ni, Qingtao, et al.
Publicado: (2020) -
Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma
por: Wang, Peng, et al.
Publicado: (2021) -
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site
por: Piga, A, et al.
Publicado: (2004)